The scientist of emerging technology and cancer biology partners with clinicians, product managers, and key opinion leaders to transform oncology products. Shruti Sharma and her team ensure that the science and product are continuously expanding and evolving. Shruti plays a crucial role in liaising with academic institutions, ensuring that research is ongoing.
Shruti is very knowledgeable and passionate about her work. She is one of the main contributors to multiple Signatera milestones and is also very friendly, helpful and great to work with! Ekaterina Kalashnikova, Sr. Scientist, Emerging Technology and Cancer Biology
Tell us a little about yourself and your background.
I have been part of the clinical oncology team at Natera for four years now and have more than 15 years of experience in the field of human genomics of complex diseases. Prior to Natera, I did my post doctorate at University of Chicago and PhD at University of Delhi.
Why did you choose this field?
Working in the field of human genomics has helped me translate my projects from bench to bedside. Behind every sample, there has always been a real person that we are trying to help!